Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05062057
Other study ID # 12409
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 6, 2022
Est. completion date February 16, 2024

Study information

Verified date May 2024
Source Indiana University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Palpitations occur in more than 25% of women as they approach menopause and after menopause. However, the etiology of menopausal palpitations has not been studied, and it is unknown whether palpitations in menopausal women are caused by underlying arrhythmias or other electrocardiographic (ECG) abnormalities. Objective: 1. The primary objective of this exploratory pilot study is to assess whether arrhythmias and/or other ECG abnormalities underlie symptomatic palpitations in peri- and postmenopausal women 2 The secondary objective is to better understand women's palpitations symptom experiences (describe the symptom, its dimensions (frequency, severity, distress, duration, temporal pattern, aggravating/alleviating factors), and any attempted or actual healthcare utilization related to the symptom (provider contacts, discussions, referrals; laboratory or other tests). In this study, 40 peri- and post-menopausal women will be enrolled to determine if they have underlying arrhythmias or other ECG abnormalities. n=20 peri/postmenopausal women who describe palpitations within the previous 2 weeks and a control group of n=20 peri/postmenopausal women who have not experienced palpitations within 6 months will be enrolled. All participants will undergo placement of a 14-day adhesive ECG monitoring patch [(Carnation Ambulatory Monitoring (CAM) patch, Bardy Diagnostics] on their chest. After wearing the patch for 14 days, the patch will be removed, and a 2nd 14-day patch will be placed, for a total of 28 days of ECG recording. Data from the adhesive ECG patches will be uploaded and an assessment of arrhythmias and other ECG changes will be made. In addition, all participants will undergo a semi-structured interview to obtain information on their palpitations symptoms experience.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date February 16, 2024
Est. primary completion date February 16, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 40 Years to 62 Years
Eligibility Inclusion Criteria: 1. Women aged 40-62 years 2. Upper limit of 62 years because this is 10 years past the median age at menopause, which is the age range when most women experience menopause symptoms 3. Peri-menopausal women - Defined as no menses in the past 3 months or menses in the past 3 months but cycles are less regular (as self-reported by the women)20 4. Postmenopausal women - No menses for 12 months or longer 5. Women with surgical menopause will be included 6. Willing to wear the adhesive heart monitor on their chest for 28 days 7. Palpitations group: women who have reported palpitations within the previous 2 weeks 8. Control group: Women who report having no palpitations within the past 6 months 9. Completion of 2-week symptom diary Exclusion Criteria: 1. Pregnant 2. Breastfeeding 3. History of arrhythmias (with the exception of sinus bradycardia, sinus arrhythmia or sinus tachycardia) 4. History of stroke 5. History of heart failure 6. Permanent pacemaker 7. Taking antiarrhythmic drugs (with the exception of ß-blockers, diltiazem or verapamil) 8. Known skin allergies (CAM patches are contraindicated) 9. Family history of skin allergies (CAM patches are contraindicated)

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Adhesive ambulatory ECG recording patches
All women in both groups will undergo sequential placement of two 14-day adhesive ambulatory ECG recording patches for a total of 28 days of ECG recording

Locations

Country Name City State
United States Indiana CTSI Clinical Research Center Indianapolis Indiana

Sponsors (2)

Lead Sponsor Collaborator
Indiana University Indiana Clinical and Translational Sciences Institute

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Arrhythmias Incidence and nature of arrhythmias in peri- and postmenopausal women who report symptomatic palpitations. Arrhythmias to be assessed include, but are not limited to:
Accelerated idioventricular rhythm
AF
Atrial flutter
Atrial tachycardia
Atrioventricular blocks (2nd and 3rd degree)
Junctional rhythm
Junctional tachycardia
Premature atrial complexes (PACs)
PVCs, including couplets, bigeminy, trigeminy
Sinus tachycardia
Supraventricular tachycardia (AV nodal reentrant tachycardia, AV reentrant tachycardia)
Ventricular tachycardia (monomorphic and polymorphic)
Any other abnormal rhythms discovered
28 days
Secondary Moment-to-moment self-report of palpitations events recorded through an event marker button 28 days
Secondary Narrative descriptions of women's symptom experiences Symptom dimensions (e.g., frequency, severity, temporal pattern) and treatment-seeking (e.g., reports to healthcare professionals, tests, ER visits) 28 days
See also
  Status Clinical Trial Phase
Completed NCT05617287 - An Exploratory Investigation of Dietary Supplementation and the Effect on Common Symptoms of Perimenopause and Menopause N/A
Withdrawn NCT04258410 - Quercetin for Cardio-Skeletal Muscle Health and Estrogen Deficiency Phase 4
Recruiting NCT05912309 - Effects of Time-restricted Eating and Exercise Training on Skeletal Muscle Mass Quantity, Quality and Function in Postmenopausal Women With Overweight and Obesity N/A
Completed NCT04079218 - Accelerated Genital Tract Aging in HIV: Estradiol Clinical Trial Phase 4
Active, not recruiting NCT03681678 - Laser Therapy for Treatment of Urogenital Symptoms in Women
Completed NCT03082040 - A Home-based Breathing Training on Menopausal Symptoms N/A
Recruiting NCT06048965 - Asia Pacific Menopause Federation Menopause Consensus
Terminated NCT03037554 - The Effects of Lateralized Thermal Sleepwear on Sleep, Skin Temperature and Skin Moisture in Menopausal Women N/A
Completed NCT03150407 - Use of J3 Bioscience Lubricating Intravaginal Ring VR101 to Relieve the Symptoms of Vaginal Dryness N/A
Completed NCT04336891 - Effect of Testosterone Treatment on Clitoral Arteries' Hemodynamic Parameters.
Not yet recruiting NCT04190927 - A New Hormone Replacement Paradigm: Physiologic Restoration Study Phase 4
Completed NCT03178695 - Inovium Ovarian Rejuvenation Trials Phase 1
Completed NCT05408273 - Vitamin D and Microvascular Function in Postmenopausal Women
Recruiting NCT04031456 - Autologous PRP Infusion May Restore Ovarian Function and May Promote Folliculogenesis in POI Patients Phase 2/Phase 3
Completed NCT05396261 - a Flexible Wound Dressing for the Management of Genital Skin Conditions N/A
Completed NCT06154798 - World Digital Detox Program for Enhancing Women's Health & Well-being N/A
Completed NCT03752060 - The Clinical Utility of Resistance Training for Improving Cardiovascular Disease Risk in Post-Menopausal Women N/A
Recruiting NCT06074120 - Low-level Laser Therapy in Genitourinary Symptoms of Menopause N/A
Recruiting NCT06192329 - Hot Water Therapy for the Treatment of Menopause-related Hot Flashes N/A
Not yet recruiting NCT06176820 - Vaginal Hyaluronic Acid, Arginine and Liposome Gel Versus Vaginal Lubricant in Postmenopausal Women With Genitourinary Syndrome of Menopause Phase 2/Phase 3